HIGHLIGHTS
- who: Maria Mazzitelli et al. from the Infectious and Tropical Diseases Unit, Padua University Hospital, Padua, Italy have published the research: Viro-Immunological, Clinical Outcomes and Costs of Switching to BIC/TAF/FTC in a Cohort of People Living with HIV: A 48-Week Prospective Analysis, in the Journal: Biomedicines 2022, 10, 1823. of 31/Oct/2021
- what: The aims of this prospective analysis were: (I) to evaluate the viroimmunological efficacy of BIC/FTC/TAF in a cohort of who switched to this regimen from any other previous at the Infectious and Tropical Diseases Unit . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.